Day: April 17, 2023

— IL-13 Superkines provide a versatile strategy for targeted delivery of anti-cancer agents to IL-13Rα2, which is overexpressed in many solid tumors but minimally expressed in normal tissues — MDNA132 and MDNA213 are novel IL-13 Superkines that are highly specific and preferentially accumulate in the microenvironment of IL-13Rα2-expressing tumors –IL-13 Empowered Superkines™ act synergistically in combination with IL-2 Superkines in aggressive models of immunologically “cold” tumors TORONTO and HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced that new preclinical data characterizing the Interleukin 13 (IL-13) Superkines, MDNA132 and MDNA213, and a series of next generation...

PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that Greg Russotti, Ph.D., ad-interim Chief Executive Officer, will participate in a fireside chat at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit on Monday, April 24, 2023 at 10:30 AM ET. A replay of the event will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 30 days following the events. About Century Therapeutics Century Therapeutics, Inc. (NASDAQ: IPSC) is a clinical-stage biotechnology company harnessing...

Vancouver, BC, April 17, 2023 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH)   (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce that it has acquired by staking eight new prospective uranium exploration properties within the Athabasca Basin of Northern Saskatchewan. These 100% owned, eight properties comprise 34,022 hectares (85,070 acres) in the Basin, which is host to the highest-grade uranium deposits in the world and is consistently ranked as a top mining jurisdiction by the Fraser Institute. Skyharbour’s New Uranium Project Portfolio Map:https://www.skyharbourltd.com/_resources/maps/SKY_SaskProject_Locator_20230320_V2A.jpg The new properties bring Skyharbour’s total land package that it has ownership interest in to 492,074 hectares (1,215,941 acres), across twenty-three properties, representing...

TORONTO and MONTREAL, April 17, 2023 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD) has made every day Earth Day through recent operational improvements that will have an important positive impact on our planet. The Company announced today that customers can now feel even better about their Goodfood meals knowing that delivery carbon emissions are permanently being offset going forward. In addition, the team has released next generation packaging to reduce plastic waste by 21 metric tonnes —equivalent to more than 2,400,000 plastic grocery bags1. In partnership with Less Emissions, Goodfood is offsetting the carbon impact of its deliveries by supporting Canadian projects, including Les Minéraux Harsco’s slag-based recycling operations in Quebec and The Net Zero Waste Inc. City of Abbotsford Composting...

Conference Call to be held Tuesday, May 9 at 8:00 a.m. Central Time HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced that it will issue its financial results for the first quarter ended March 31, 2023 on Monday, May 8, 2023, after the close of the stock market. A conference call and audio webcast with analysts and investors will be held the next day, May 9, at 8:00 a.m. Central Time to discuss the results and answer questions. Live conference call: 800-715-9871 Live and archived webcast: https://edge.media-server.com/mmc/p/7kn5kim4 or the Company’s website at Orion Group Holdings, Inc. – Investor Relations & Shareholder Contact (oriongroupholdingsinc.com) About Orion Group Holdings, Inc. Orion Group...

WASHINGTON, April 17, 2023 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that the Technology segment has entered into a partnership with Smarsh, a global leader in digital communications compliance and intelligence. The collaboration with Smarsh will enhance FTI Technology’s offerings that solve unmitigated risk and compliance challenges through sophisticated, integrated and expert-led technology solutions. FTI Technology is now one of a small group of providers that can deliver hands-on expertise with Smarsh implementations, enhancing the firm’s position in responding to client demand for technology solutions that enable improvements across governance, compliance monitoring and other adjacent functions. FTI Technology’s recent report, The Most Valuable, Vulnerable Commodity: Data Establishes a New Era of...

TORONTO, Ontario, April 17, 2023 (GLOBE NEWSWIRE) — Rhyolite Resources Ltd. (TSXV: RYE) (“Rhyolite” or the “Company”) reports that its Chief Financial Officer, Cybill Tsung, has resigned her position to pursue other opportunities effective May 5, 2023. Rhyolite will appoint Mr. Quinn Martin as CFO effective May 5, 2023. In the coming weeks, Ms. Tsung will assist with the transition of duties to Mr. Martin, including the completion of Rhyolite’s 2022 annual financial statements. “I would like to thank Cybill, who has been an integral part of Rhyolite over the past two and a half years, for her contribution and for making this transition as smooth as possible and wish her continued success in her future endeavors,” says Rhyolite CEO Richard Graham. Mr. Martin is a Chartered Professional Accountant (CPA, CA) with over...

Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to be named Lead Independent Director TARRYTOWN, N.Y., April 17, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that P. Roy Vagelos, M.D., will retire from his role as Chair of the Company’s Board of Directors and will not stand for reelection at the Company’s 2023 Annual Meeting of Shareholders. Dr. Vagelos has served as Chair since January 1995 and will complete his current term through the conclusion of the Annual Meeting on June 9, 2023. Effective upon the conclusion of that meeting, the Board plans to appoint Leonard S. Schleifer, M.D., Ph.D., and George D. Yancopoulos, M.D., Ph.D., as Co-Chairs of the Board, in addition to their roles as President and Chief Executive Officer...